ClinConnect ClinConnect Logo
Search / Trial NCT05730933

An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.

Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Feb 15, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Eosinophilic Esophagitis Maintenance Treatment Compliance Intervention

ClinConnect Summary

This clinical trial is studying ways to help adults with eosinophilic esophagitis (EoE) stick to their treatment plans. EoE is a condition where too many eosinophils, a type of white blood cell, build up in the esophagus, leading to symptoms like difficulty swallowing and pain. Many patients struggle to follow their prescribed treatments over the long term, so the researchers want to see if giving more education, regular follow-ups, and reminders can encourage better adherence to treatment.

To participate in this trial, you need to be an adult over 18 years old who has been diagnosed with EoE through a biopsy, and you should be currently receiving or about to start maintenance treatment, such as medications that help reduce inflammation. If you have other serious health issues, are receiving another investigational treatment, or need a procedure to widen your esophagus, you won't be eligible for this study. Participants will receive additional support and information throughout the trial to help them manage their condition more effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Written informed consent
  • Male or female patient
  • Age \>18 years
  • Previous diagnosis of EoE, confirmed by histopathology, with the presence of \>15 eosinophilic granulocytes per high power field (hpf) in esophageal biopsies
  • Current maintenance treatment for EoE with a PPI or swallowed topical corticosteroids or about to start with these maintenance medications as decided during regular clinical practice
  • Exclusion Criteria:
  • Severe and clinically unstable concomitant disease that may interfere with the subject's ability to participate in the study
  • Receive investigational treatment during the study
  • Dilation of esophagus required
  • Insufficient Dutch or English language skills to understand patient information leaflets

About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)

The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.

Locations

Amsterdam, Noord Holland, Netherlands

Amsterdam, Noord Holland, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials